N. M. Faber, “Floyd Landis: An Unsafe Conviction, Regardless of Quality of Data,” Clinica Chimica Acta, Vol. 411, No. 1-2, 2010, pp. 117-118. doi:10.1016/j.cca.2009.10.001
has been cited by the following article:
TITLE: Substance Identification in Anti-Doping Control by Means of Mass Spectrometry. Data Reduction and Decision Criteria
AUTHORS: Mats Larsson
KEYWORDS: Substance Identification, Anti-Doping, Mass Spectrometry, Data Reduction
JOURNAL NAME: Journal of Analytical Sciences, Methods and Instrumentation, Vol.1 No.2, December 16, 2011
ABSTRACT: A real doping case for which the national-level reviewing body deemed it probable that a misidentification of the national-level athlete’s sample occurred at the WADA accredited laboratory, thus making the athlete in this case strictly anonymous, is used to discuss criteria for data reduction and tolerance windows in GC-MS and LC-MS/MS. Stricter criteria for data reduction would remedy the present ambiguities.